Anju Bhardwaj, Ismael Salas De Armas, Dina Al Rameni, Manish Patel, Mehmet H. Akay, Biswajit Kar, Igor D. Gregoric
{"title":"在心源性休克患者中使用Impella 5.5作为决定、恢复或终点治疗的桥梁","authors":"Anju Bhardwaj, Ismael Salas De Armas, Dina Al Rameni, Manish Patel, Mehmet H. Akay, Biswajit Kar, Igor D. Gregoric","doi":"10.1016/j.ihjccr.2023.06.002","DOIUrl":null,"url":null,"abstract":"<div><p>The overall morbidity and mortality rates of cardiogenic shock are high. The Impella 5.5 is a temporary mechanical circulatory support device that treats cardiogenic shock by supporting a failing ventricle. It is used as a bridge to advanced therapy, decision, or recovery. We report our initial experience with this device.</p></div>","PeriodicalId":100653,"journal":{"name":"IHJ Cardiovascular Case Reports (CVCR)","volume":"7 2","pages":"Pages 61-64"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Use of Impella 5.5 in patients with cardiogenic shock as a bridge to decision, recovery, or destination therapy\",\"authors\":\"Anju Bhardwaj, Ismael Salas De Armas, Dina Al Rameni, Manish Patel, Mehmet H. Akay, Biswajit Kar, Igor D. Gregoric\",\"doi\":\"10.1016/j.ihjccr.2023.06.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The overall morbidity and mortality rates of cardiogenic shock are high. The Impella 5.5 is a temporary mechanical circulatory support device that treats cardiogenic shock by supporting a failing ventricle. It is used as a bridge to advanced therapy, decision, or recovery. We report our initial experience with this device.</p></div>\",\"PeriodicalId\":100653,\"journal\":{\"name\":\"IHJ Cardiovascular Case Reports (CVCR)\",\"volume\":\"7 2\",\"pages\":\"Pages 61-64\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"IHJ Cardiovascular Case Reports (CVCR)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2468600X23000257\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"IHJ Cardiovascular Case Reports (CVCR)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468600X23000257","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Use of Impella 5.5 in patients with cardiogenic shock as a bridge to decision, recovery, or destination therapy
The overall morbidity and mortality rates of cardiogenic shock are high. The Impella 5.5 is a temporary mechanical circulatory support device that treats cardiogenic shock by supporting a failing ventricle. It is used as a bridge to advanced therapy, decision, or recovery. We report our initial experience with this device.